Menkes disease patients, who lack the functional Cu transporter ATP7A and have impaired Cu delivery to the brain, show hypomyelination, abnormal vasculature, catecholamine misbalance, defects in axonal arborization and synaptogenesis, neuronal degeneration, and other pathologies (see Refs. Here, ATP7A is linked to Menkes disease.